| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/2005 | CN1602841A Immuno-modulatory agents administration form for whole body or local immunity disorder |
| 04/06/2005 | CN1195863C Retroviral vectors |
| 04/06/2005 | CN1195860C Delivery of biologically active polypeptides |
| 04/06/2005 | CN1195788C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195772C Nb heterocyclic 8-modified adenosine derivs. |
| 04/06/2005 | CN1195770C Preparation of d4T from 5-methyl uridine |
| 04/06/2005 | CN1195769C Natural antitumor or antiviral substances and use of the same |
| 04/06/2005 | CN1195768C 3'-substd. nucleoside derivs. |
| 04/06/2005 | CN1195767C Antithrombotic compound |
| 04/06/2005 | CN1195766C Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195758C Optical pure analog of camptothecine |
| 04/06/2005 | CN1195757C Optically pure camptothecin analogues |
| 04/06/2005 | CN1195756C Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 04/06/2005 | CN1195755C Pyrrolo [2, 3-d] pyrimidine compounds |
| 04/06/2005 | CN1195754C Phenanthroline-7-one derivs. and their therapeutic applications |
| 04/06/2005 | CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195747C 8, 8a-dihydro-indeno [1, 2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195740C Pharmaceutical compositions comprising 2-quinolones |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195728C Novel compounds to treat diabetes and associated conditions |
| 04/06/2005 | CN1195549C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 04/06/2005 | CN1195548C Stable mitoxantron solutions |
| 04/06/2005 | CN1195547C Preventives / remedies for glaucoma |
| 04/06/2005 | CN1195542C Preventives for hepatopathy |
| 04/06/2005 | CN1195539C Medicine for treating cough |
| 04/06/2005 | CN1195537C External-applied Chinese medicine for treating hypertension and its preparing process |
| 04/06/2005 | CN1195527C Hydroypropyl-beta-cyclodextrin inclusion compound of Rhizoma Zedoariae oil and preparation and preparing method |
| 04/06/2005 | CN1195526C Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
| 04/06/2005 | CN1195525C Antitumor agents comprising silicon and nitrogen containing compounds as the principal agent |
| 04/06/2005 | CN1195524C Use of benzenesulfonyl (thio) ureas in combination with beta-receptor retarder for treatment and prophylaxis of dysfunctions of autonomous nervous system |
| 04/06/2005 | CN1195523C Topical compositions for prostaglandin E1 delivery |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/06/2005 | CN1195521C Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 04/06/2005 | CN1195520C Compound antibacterial anti-inflammatory for animals and poultry |
| 04/06/2005 | CN1195519C A composition of a 5-HT reuptake inhibitor and a h5-HT 1B antagonist or partial agonist |
| 04/06/2005 | CN1195518C Sustained release tablet formulations to treat Parkinson disease |
| 04/06/2005 | CN1195517C Rationed fenmameimin drops |
| 04/06/2005 | CN1195516C Use of fluorinated triazoles for preparing medicine of treating pain |
| 04/06/2005 | CN1195515C Amide derivatives for antiangiogenic and/or antitumorgenic use |
| 04/06/2005 | CN1195514C Metabolites of ecteinascidin 743 |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/06/2005 | CN1195512C Use of fatty materials for prevention or reduction of microorganism adherence on skin and/or mucous membrane |
| 04/06/2005 | CN1195511C The use of fumaric acid derivatives in transplant medicine |
| 04/06/2005 | CN1195510C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 04/06/2005 | CN1195509C Aminoethanesulfonic acid-containing preparations |
| 04/06/2005 | CN1195508C Use of inhibitors of sodium-hydrogen pump for production of medicament for decreaing undesired effects of substances on heart |
| 04/06/2005 | CN1195507C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 G/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 04/06/2005 | CN1195506C Transdermal therapeutic system with improved stability and method for production thereof |
| 04/06/2005 | CN1195504C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 04/06/2005 | CN1195503C Transdermal patch and topical compositions comprising propylnorapomorphine |
| 04/06/2005 | CN1195501C Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
| 04/06/2005 | CN1195500C Orally disintegrable tablet |
| 04/06/2005 | CN1195499C Enteric coated pharmaceutical tablet and method of manufacturing |
| 04/06/2005 | CN1195497C Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 04/06/2005 | CN1195496C Controlled release formulation for treating COPD |
| 04/06/2005 | CN1195495C Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/06/2005 | CN1195493C Absorbable silicon implants containing beneficial substance |
| 04/06/2005 | CN1195492C 皮肤护理组合物 Skin care compositions |
| 04/06/2005 | CN1195488C Method for scavenging free radical by orange extracted liquor |
| 04/06/2005 | CN1195475C 化学去皮剂 Chemical peeling agents |
| 04/05/2005 | US6875891 Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts |
| 04/05/2005 | US6875886 Modified PSMA ligands and uses related thereto |
| 04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
| 04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
| 04/05/2005 | US6875877 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875862 Radiating with radioactive rays a mixture of an alkyl, a hydroxyalkyl and/or carboxyalkyl cellulose; medical products, cosmetics, sanitary products and an agricultural water retention agent; a chromatography carrier; soil improver |
| 04/05/2005 | US6875859 Heterocyclic compounds and their use in the detection of nucleic acids |
| 04/05/2005 | US6875840 Overcoating medical equipment with nitrosylated cyclodextrin |
| 04/05/2005 | US6875793 Once-a-day controlled release sulfonylurea formulation |
| 04/05/2005 | US6875792 Inhibition of glutamine synthetase; antiswelling and antiepileptic agents |
| 04/05/2005 | US6875791 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 04/05/2005 | US6875790 Viricides |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | US6875788 Non-insulin dependent diabetes, antidiabetic agents, dietetics, antilipemic agents, anticholesterol agents, cardiovascular disorders |
| 04/05/2005 | US6875787 Vision defects; reducing pressure in eyes |
| 04/05/2005 | US6875786 Promoters of bone marrow cells |
| 04/05/2005 | US6875782 Antidiabetic agents, dietetics, anticancer agents |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875777 Compounds |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875773 Veterinary medicine; therapy for retrovirus infections; synergistic mixture of azidothymidine, lamivudine and protease inhibitor; then body radiation |
| 04/05/2005 | US6875772 [1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists |
| 04/05/2005 | US6875771 Pyridopyrimidine derivatives as 5-HT6 antagonists |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875762 Tetracyclic azepinoindole compounds |
| 04/05/2005 | US6875757 LPA receptor agonists and antagonists and methods of use |
| 04/05/2005 | US6875755 Antithrombotic compound |